Keyphrases
Quality of Life
64%
Regulatory Agencies
37%
Health-related Quality of Life
36%
Dermatology Life Quality Index
27%
Patient-reported Outcomes
27%
Patient-Reported Outcomes Measurement Information System (PROMIS)
22%
Family Members
22%
Regulatory Approval
21%
PRO Measure
19%
Psoriasis
19%
Pharmaceutical Industry
18%
Skin Diseases
18%
Decision Quality
17%
Effectiveness Evaluation
17%
Canada
17%
Quality of Life Assessment
17%
Pharmaceutical Companies
17%
South Africa
16%
Self-reported Outcomes
15%
Health Technology Assessment
14%
Review Process
14%
Efficiency Evaluation
14%
Dermatology Outpatients
13%
Regulatory Harmonization
13%
FROM-16
12%
European Countries
12%
Dermatologist
12%
Atopic Dermatitis
12%
Quality of Life Measurement
12%
Australia
11%
Clinical Trials
11%
Quality of Life Instruments
11%
Index Score
11%
South African
11%
Pyruvate Kinase Deficiency
11%
Cyclosporine
11%
Hyperhidrosis
11%
Decision-making Process
10%
ZaZiBoNa
9%
Marketing Authorization
9%
Joint Assessment Procedure
9%
Content Validity
9%
Regulatory Performance
9%
East African Community
9%
Psoriasis Severity
9%
Patient-centered
9%
EQ-5D
9%
New Medicines
9%
Health Products
8%
Registration Process
8%
Nursing and Health Professions
Quality of Life
100%
Patient-Reported Outcome
31%
Disease
30%
Dermatology Life Quality Index
26%
Practice Guideline
17%
Psychometry
15%
Clinical Practice
14%
Outpatient
14%
Skin Disease
13%
Systematic Review
11%
Quality of Life Measure
10%
Psoriasis
10%
Content Validity
9%
Internal Consistency
9%
Malignant Neoplasm
9%
Hematologic Malignancy
9%
Clinical Decision Making
8%
Hyperhidrosis
8%
Pyruvate Kinase
8%
Correlation Coefficient
8%
Outcomes Research
8%
Dermatologist
7%
Dermatitis
7%
Factor Analysis
6%
Atopic Dermatitis
6%
Quality of Life Index
6%
Chronic Disease
6%
Acne
5%
Minimal Clinically Important Difference
5%
Cronbach Alpha Coefficient
5%
Area under the Curve
5%
Adolescent
5%
Rasch Analysis
5%
Outpatient Department
5%
Medicine and Dentistry
Quality of Life
62%
Dermatology
28%
Dermatology Life Quality Index
22%
Medicine
21%
Dermatosis
21%
Disease
19%
Atopic Dermatitis
14%
Patient-Reported Outcome
12%
Pyruvate Kinase Deficiency
11%
Psychometry
10%
Psoriasis
10%
Clinical Trial
9%
Consultation
9%
Outpatient
8%
Acneiform Eruption
8%
Cyclosporine
8%
Technology Assessment
7%
Health Technology
7%
Dermatitis
7%
Clinician
7%
Dermatological Disease
6%
Pruritus
6%
Venereology
6%
Hidradenitis Suppurativa
5%
Decision Making
5%
Clinical Decision Making
5%
Adolescence
5%
Systematic Review
5%
Placebo
5%
Prurigo
5%
